Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Latest Information Update: 23 Feb 2024
At a glance
- Drugs Tivanisiran (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors PharmaMar; Sylentis
- 16 Feb 2024 Status changed from recruiting to completed.
- 09 Feb 2024 Primary endpoint (Change from baseline in Dry Eye Symptom score) has not been met.
- 09 Feb 2024 Results published in the Sylentis Media Release.